# IL-6 as a Biomarker for Personalized Treatment of PR

> **NCT04779983** · — · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 200 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04779983
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-18
- **Primary completion:** 2021-07-30
- **Final completion:** 2021-08-01
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2021-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04779983

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04779983, "IL-6 as a Biomarker for Personalized Treatment of PR". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04779983. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*